<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>Press Releases | Boston Scientific</title>
<link>http://bostonscientific.mediaroom.com/</link>
<description>Boston Scientific</description>
<item>
<title>Boston Scientific To Participate In The 38th Annual Deutsche Bank 2013 Healthcare Conference</title>
<link>http://bostonscientific.mediaroom.com/2013-05-24-Boston-Scientific-To-Participate-In-The-38th-Annual-Deutsche-Bank-2013-Healthcare-Conference</link>
<description></description>
<pubDate>Fri, 24 May 2013 11:00:00 -0400</pubDate>
<guid>http://bostonscientific.mediaroom.com/2013-05-24-Boston-Scientific-To-Participate-In-The-38th-Annual-Deutsche-Bank-2013-Healthcare-Conference</guid>
</item>
<item>
<title>New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System</title>
<link>http://bostonscientific.mediaroom.com/2013-05-22-New-Data-Demonstrate-Significant-And-Sustained-Blood-Pressure-Reduction-With-Boston-Scientific-Vessix-Renal-Denervation-System</link>
<description>Interim Data from REDUCE-HTN Clinical Program Presented Today at EuroPCR</description>
<pubDate>Wed, 22 May 2013 12:20:00 -0400</pubDate>
<guid>http://bostonscientific.mediaroom.com/2013-05-22-New-Data-Demonstrate-Significant-And-Sustained-Blood-Pressure-Reduction-With-Boston-Scientific-Vessix-Renal-Denervation-System</guid>
</item>
<item>
<title>Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial</title>
<link>http://bostonscientific.mediaroom.com/2013-05-22-Boston-Scientific-Reports-Lotus-Valve-System-Met-Primary-Performance-Endpoint-in-REPRISE-II-Trial</link>
<description>New Data Presented In Late-Breaking Clinical Trial Session At EuroPCR Demonstrated Successful Deployment Of The Lotus™ Valve In The First 60 Patients With Minimal Paravalvular Regurgitation At 30 Days</description>
<pubDate>Wed, 22 May 2013 10:41:00 -0400</pubDate>
<guid>http://bostonscientific.mediaroom.com/2013-05-22-Boston-Scientific-Reports-Lotus-Valve-System-Met-Primary-Performance-Endpoint-in-REPRISE-II-Trial</guid>
</item>
<item>
<title>Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data</title>
<link>http://bostonscientific.mediaroom.com/2013-05-22-Boston-Scientific-Promus-PREMIER-And-SYNERGY-Drug-Eluting-Stent-Systems-Provide-Exceptional-Safety-And-Efficacy-Data</link>
<description></description>
<pubDate>Wed, 22 May 2013 09:13:00 -0400</pubDate>
<guid>http://bostonscientific.mediaroom.com/2013-05-22-Boston-Scientific-Promus-PREMIER-And-SYNERGY-Drug-Eluting-Stent-Systems-Provide-Exceptional-Safety-And-Efficacy-Data</guid>
</item>
<item>
<title>Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma</title>
<link>http://bostonscientific.mediaroom.com/2013-05-21-Boston-Scientific-Long-Term-Data-Demonstrate-Bronchial-Thermoplasty-Treatment-Benefits-Persist-Out-to-Five-Years-in-Patients-with-Severe-Asthma</link>
<description></description>
<pubDate>Tue, 21 May 2013 11:46:00 -0400</pubDate>
<guid>http://bostonscientific.mediaroom.com/2013-05-21-Boston-Scientific-Long-Term-Data-Demonstrate-Bronchial-Thermoplasty-Treatment-Benefits-Persist-Out-to-Five-Years-in-Patients-with-Severe-Asthma</guid>
</item>
</channel>
</rss>
